BELLICUM PHARMACEUTICALS, INC — Form D

BELLICUM PHARMACEUTICALS, INC of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2009-03-31. The offering totals $1.5M, of which $500K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Kevin SlawinDirectorHouston, TX
Kevin SlawinExecutive OfficerHouston, TX
Thomas J FarrellDirectorSan Diego, CA
Thomas J FarrellExecutive OfficerSan Diego, CA
Dennis K StoneDirectorHouston, TX
David M SpencerExecutive OfficerHouston, TX
Annemarie K MoseleyExecutive OfficerHouston, TX
Kevin M SlawinDirectorHouston, TX
Kevin M SlawinExecutive OfficerHouston, TX
James F BrownDirectorHouston, TX
Frank M McGuyerDirectorHouston, TX
Ken K MoseleyExecutive OfficerHouston, TX
Joseph K SenesacExecutive OfficerHouston, TX
Thomas FarrellDirectorHouston, TX
Thomas FarrellExecutive OfficerHouston, TX
David SpencerExecutive OfficerHouston, TX
Frank McGuyerDirectorHouston, TX

Other filings by this issuer (5)

FiledFormOfferingSold
2014-09-03D$94.4M$94.4M
2013-10-16D/A$35.0M$19.6M
2012-03-22D$25.0M$19.9M
2010-10-25D$3.0M$1.2M
2009-10-21D$2.5M$1.3M

More